LENNAR CORP-A (LEN) Fundamental Analysis & Valuation

NYSE:LEN • US5260571048

Current stock price

88.41 USD
-3.91 (-4.24%)
Last:

This LEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. LEN Profitability Analysis

1.1 Basic Checks

  • In the past year LEN was profitable.
  • In the past year LEN had a positive cash flow from operations.
  • LEN had positive earnings in each of the past 5 years.
  • In the past 5 years LEN always reported a positive cash flow from operatings.
LEN Yearly Net Income VS EBIT VS OCF VS FCFLEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • LEN has a Return On Assets of 5.33%. This is in the better half of the industry: LEN outperforms 61.67% of its industry peers.
  • LEN has a Return On Equity (8.09%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of LEN (5.50%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for LEN is in line with the industry average of 8.88%.
  • The 3 year average ROIC (9.80%) for LEN is well above the current ROIC(5.50%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.33%
ROE 8.09%
ROIC 5.5%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
LEN Yearly ROA, ROE, ROICLEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • LEN has a Profit Margin of 5.34%. This is in the better half of the industry: LEN outperforms 61.67% of its industry peers.
  • In the last couple of years the Profit Margin of LEN has declined.
  • LEN has a Operating Margin of 6.89%. This is comparable to the rest of the industry: LEN outperforms 55.00% of its industry peers.
  • LEN's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 9.35%, LEN is doing worse than 93.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LEN has declined.
Industry RankSector Rank
OM 6.89%
PM (TTM) 5.34%
GM 9.35%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
LEN Yearly Profit, Operating, Gross MarginsLEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. LEN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LEN is still creating some value.
  • LEN has less shares outstanding than it did 1 year ago.
  • LEN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LEN has a worse debt to assets ratio.
LEN Yearly Shares OutstandingLEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LEN Yearly Total Debt VS Total AssetsLEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.87 indicates that LEN is not in any danger for bankruptcy at the moment.
  • LEN has a Altman-Z score of 3.87. This is in the better half of the industry: LEN outperforms 68.33% of its industry peers.
  • LEN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • LEN has a Debt to Equity ratio of 0.19. This is in the better half of the industry: LEN outperforms 63.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 3.87
ROIC/WACC0.61
WACC8.98%
LEN Yearly LT Debt VS Equity VS FCFLEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • LEN has a Current Ratio of 8.73. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
  • LEN has a better Current ratio (8.73) than 85.00% of its industry peers.
  • A Quick Ratio of 1.75 indicates that LEN should not have too much problems paying its short term obligations.
  • LEN has a better Quick ratio (1.75) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 8.73
Quick Ratio 1.75
LEN Yearly Current Assets VS Current LiabilitesLEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. LEN Growth Analysis

3.1 Past

  • The earnings per share for LEN have decreased strongly by -49.31% in the last year.
  • LEN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.33% yearly.
  • LEN shows a decrease in Revenue. In the last year, the revenue decreased by -7.23%.
  • Measured over the past years, LEN shows a quite strong growth in Revenue. The Revenue has been growing by 8.74% on average per year.
EPS 1Y (TTM)-49.31%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.55%
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-13.26%

3.2 Future

  • Based on estimates for the next years, LEN will show a very strong growth in Earnings Per Share. The EPS will grow by 26.08% on average per year.
  • The Revenue is expected to grow by 6.58% on average over the next years.
EPS Next Y-21.39%
EPS Next 2Y-1.46%
EPS Next 3Y8.24%
EPS Next 5Y26.08%
Revenue Next Year-2.92%
Revenue Next 2Y0.68%
Revenue Next 3Y3.38%
Revenue Next 5Y6.58%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LEN Yearly Revenue VS EstimatesLEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
LEN Yearly EPS VS EstimatesLEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. LEN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.70, the valuation of LEN can be described as correct.
  • The rest of the industry has a similar Price/Earnings ratio as LEN.
  • The average S&P500 Price/Earnings ratio is at 26.91. LEN is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 11.40, the valuation of LEN can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LEN indicates a somewhat cheap valuation: LEN is cheaper than 65.00% of the companies listed in the same industry.
  • LEN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 12.7
Fwd PE 11.4
LEN Price Earnings VS Forward Price EarningsLEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LEN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.2
LEN Per share dataLEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)38.65
EPS Next 2Y-1.46%
EPS Next 3Y8.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. LEN Dividend Analysis

5.1 Amount

  • LEN has a Yearly Dividend Yield of 2.12%.
  • Compared to an average industry Dividend Yield of 1.29, LEN pays a bit more dividend than its industry peers.
  • LEN's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of LEN is nicely growing with an annual growth rate of 26.65%!
  • LEN has paid a dividend for at least 10 years, which is a reliable track record.
  • LEN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)26.65%
Div Incr Years0
Div Non Decr Years16
LEN Yearly Dividends per shareLEN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • LEN pays out 28.96% of its income as dividend. This is a sustainable payout ratio.
  • LEN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.96%
EPS Next 2Y-1.46%
EPS Next 3Y8.24%
LEN Yearly Income VS Free CF VS DividendLEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LEN Dividend Payout.LEN Dividend Payout, showing the Payout Ratio.LEN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

LEN Fundamentals: All Metrics, Ratios and Statistics

LENNAR CORP-A

NYSE:LEN (4/29/2026, 3:37:09 PM)

88.41

-3.91 (-4.24%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Industry Strength42.86
Industry Growth6.21
Earnings (Last)03-12
Earnings (Next)06-15
Inst Owners93.16%
Inst Owner Change0.21%
Ins Owners1.33%
Ins Owner Change1.93%
Market Cap21.78B
Revenue(TTM)33.17B
Net Income(TTM)1.77B
Analysts51.85
Price Target93.86 (6.16%)
Short Float %6.16%
Short Ratio4.13
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend2.02
Dividend Growth(5Y)26.65%
DP28.96%
Div Incr Years0
Div Non Decr Years16
Ex-Date04-22
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.84%
Min EPS beat(2)-13.73%
Max EPS beat(2)-3.95%
EPS beat(4)1
Avg EPS beat(4)-4.37%
Min EPS beat(4)-13.73%
Max EPS beat(4)7.91%
EPS beat(8)4
Avg EPS beat(8)1.57%
EPS beat(12)8
Avg EPS beat(12)5.77%
EPS beat(16)11
Avg EPS beat(16)6.93%
Revenue beat(2)1
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-4.78%
Max Revenue beat(2)2.85%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.78%
Max Revenue beat(4)2.85%
Revenue beat(8)5
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)1.4%
Revenue beat(16)10
Avg Revenue beat(16)1.61%
PT rev (1m)-15.53%
PT rev (3m)-16.57%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-16.65%
EPS NY rev (1m)-6.91%
EPS NY rev (3m)-10.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.63%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-1.2%
Valuation
Industry RankSector Rank
PE 12.7
Fwd PE 11.4
P/S 0.66
P/FCF N/A
P/OCF 300.96
P/B 1
P/tB 1.18
EV/EBITDA 10.2
EPS(TTM)6.96
EY7.87%
EPS(NY)7.76
Fwd EY8.77%
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.29
OCFY0.33%
SpS134.69
BVpS88.83
TBVpS74.86
PEG (NY)N/A
PEG (5Y)38.65
Graham Number117.945 (33.41%)
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 8.09%
ROCE 7.26%
ROIC 5.5%
ROICexc 5.89%
ROICexgc 13.47%
OM 6.89%
PM (TTM) 5.34%
GM 9.35%
FCFM N/A
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
ROICexc(3y)11.54%
ROICexc(5y)13.41%
ROICexgc(3y)16.37%
ROICexgc(5y)17.4%
ROCE(3y)12.94%
ROCE(5y)15.31%
ROICexgc growth 3Y-14.19%
ROICexgc growth 5Y2.33%
ROICexc growth 3Y-24.42%
ROICexc growth 5Y-4.96%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 1.68
Cap/Depr 119.22%
Cap/Sales 0.49%
Interest Coverage 250
Cash Conversion 2.99%
Profit Quality N/A
Current Ratio 8.73
Quick Ratio 1.75
Altman-Z 3.87
F-Score4
WACC8.98%
ROIC/WACC0.61
Cap/Depr(3y)126.5%
Cap/Depr(5y)104.2%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.35%
Profit Quality(3y)63.09%
Profit Quality(5y)63.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-49.31%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.55%
EPS Next Y-21.39%
EPS Next 2Y-1.46%
EPS Next 3Y8.24%
EPS Next 5Y26.08%
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-13.26%
Revenue Next Year-2.92%
Revenue Next 2Y0.68%
Revenue Next 3Y3.38%
Revenue Next 5Y6.58%
EBIT growth 1Y-53.46%
EBIT growth 3Y-26.63%
EBIT growth 5Y-4.23%
EBIT Next Year-23.35%
EBIT Next 3Y5.75%
EBIT Next 5Y17.37%
FCF growth 1Y-102.05%
FCF growth 3Y-79.37%
FCF growth 5Y-63.1%
OCF growth 1Y-98.42%
OCF growth 3Y-59.51%
OCF growth 5Y-44.7%

LENNAR CORP-A / LEN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LENNAR CORP-A (LEN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.


What is the valuation status for LEN stock?

ChartMill assigns a valuation rating of 3 / 10 to LENNAR CORP-A (LEN). This can be considered as Overvalued.


Can you provide the profitability details for LENNAR CORP-A?

LENNAR CORP-A (LEN) has a profitability rating of 5 / 10.


What is the financial health of LENNAR CORP-A (LEN) stock?

The financial health rating of LENNAR CORP-A (LEN) is 6 / 10.


Can you provide the expected EPS growth for LEN stock?

The Earnings per Share (EPS) of LENNAR CORP-A (LEN) is expected to decline by -21.39% in the next year.